With huge thanks to all the tutors, students and the @gatesfoundation.bsky.social for making this all possible!
24.11.2025 13:51 — 👍 1 🔁 0 💬 0 📌 0
Another successful "Intro to TB Modelling" course in Copenhagen at #WLHC2025. Over 70 joined to learn about TB modelling!
Followed by the now-traditional TB Modelling and Analysis Consortium social, which was also very well-attended and a lot of fun.
24.11.2025 13:51 — 👍 12 🔁 7 💬 1 📌 1
Information for applicants - MRC London Intercollegiate Doctoral Training Partnership Studentships
MRC LID studentship information for applicants How to Apply Projects Studentship funding Studentship options Studentship...
@lshtm-tbmod.bsky.social is offering multiple PhD opportunities through MRC LID, deadline 14 Jan. More details: mrc-lid.lshtm.ac.uk/applicants/
Projects include
#1 TB & screening
#2 TB & climate change
#3 TB & vaccines
#4 TB & influenza
#5 TB & prevention
@cmmid-lshtm.bsky.social @lshtm.bsky.social
18.11.2025 14:49 — 👍 7 🔁 7 💬 1 📌 1
What’s a #UnionConf without the TB modelling course? Packed room again for a long day of intro to modelling.
@lshtm-tbmod.bsky.social @tb-mac.bsky.social #WCLH2025 #TBSky
18.11.2025 10:28 — 👍 17 🔁 5 💬 1 📌 1
Modelling Like an Experimentalist
Dahlin et al. (2024) apply experimental thinking to a model of mosquito-borne disease transmissions.
"Validate With Simulated Truth: A first habit is to test whether an analytical pipeline can recover known conditions."
Very good advice below. So much COVID nonsense (e.g. 'immunological dark matter') basically came down to a non-identifiable model that hadn't been properly tested.
09.11.2025 21:18 — 👍 49 🔁 6 💬 3 📌 2
Projects - MRC London Intercollegiate Doctoral Training Partnership Studentships
2026-27 MRC LID POTENTIAL RESEARCH PROJECTS MRC LID is offering 40 distinct potential projects for...
Excited to say that we have a PhD project out on our age-sex research - looking at combinations of #AMR. With the fabulous @jodi-lindsay.bsky.social and Lanre Edun! Do get in touch for more information!
mrc-lid.lshtm.ac.uk/2026-27-proj...
10.11.2025 16:05 — 👍 1 🔁 4 💬 0 📌 0
UK to put 250,000 lives at risk from HIV, TB and malaria with aid cuts
Exclusive: The UK is expected to pledge £850m to the Global Fund to Fight Aids, TB and Malaria – a cut of 15 per cent – despite previous assurances that funding would be protected
Ahead of The Union World Conference on Lung Health, Katherine Horton provides @the-independent.com with insights into the devastating impact of the funding cuts on global health, particularly tuberculosis.
Be sure to read about the threat of UK aid cuts: www.independent.co.uk/news/uk/poli...
10.11.2025 21:41 — 👍 4 🔁 3 💬 1 📌 1
Climate change and tuberculosis: an analytical framework
Climate change is likely to exacerbate a range of determinants that drive tuberculosis,
the world's leading cause of death from a single infectious agent. However, tuberculosis
is often neglected in w...
Our framework that informed the @who.int TB & climate change policy brief out now in @lancetrespirmed.bsky.social, exploring the intersections and implications of climate change for the TB epidemic. Key message? TB should be considered a climate-sensitive disease
www.thelancet.com/journals/lan...
31.10.2025 09:12 — 👍 22 🔁 18 💬 1 📌 0
Announcement Awardees | TBVI Awards 2026 - TuBerculosis Vaccine Initiative
Announcement Awardees | TBVI Awards 2026
✨ I’m so honoured to have been awarded one of this year’s TBVI Awards! ✨
I’m truly grateful for this recognition and excited for the opportunity to showcase my research at the TBVI Annual Meeting in January 2026.
#TBVI #tuberculosis #vaccines
tbvi.eu/announcement...
28.10.2025 13:24 — 👍 9 🔁 1 💬 0 📌 0
A global analysis of patterns of tuberculosis exposure and transmission
Tuberculosis (TB) is a major public health concern and the leading infectious cause of mortality globally. The disease exhibits strong prevalence patterns by age and sex, but the implications of these...
Understanding patterns of #TB exposure and transmission is needed for targeted prevention strategies. In our latest pre-print, @petedodd24.bsky.social and I estimated the proportion of TB exposure to and transmission from sex and age groups for 177 countries.
bit.ly/4nbV492
12.10.2025 12:51 — 👍 16 🔁 17 💬 1 📌 0
We are inviting applications for postdoctoral fellows in immunology of TB at the South African Tuberculosis Vaccine Initiative, University of Cape Town. For more information see the attached ad:
idm.uct.ac.za/media/739223
09.10.2025 11:28 — 👍 82 🔁 40 💬 4 📌 3
About half of people with #TB are asymptomatic (aTB). Calls have been made to stratify treatment and estimate incidence based on aTB case definitions
In this preprint we raise concerns that symptoms are an inadequate & inconsistent classifier of TB state, being highly influenced by context
⬇️link
15.08.2025 18:02 — 👍 12 🔁 4 💬 2 📌 1
Our work on modelling population-wide screening in Viet Nam is now available in PLOS Global Public Health! tinyurl.com/3ymhuj5s
11.09.2025 03:54 — 👍 12 🔁 5 💬 0 📌 3
Differences in Tuberculosis Prevalence by Sex Over 1993-2024: A Systematic Review and Meta-Analysis
Background: Tuberculosis (TB) prevalence is higher among men than women in low- and middle-income countries (LMICs). However, summary measures of sex difference
1/ It’s been 10 years (😮) since we reported that #TB prevalence was twice as high in men as in women.
📢 Our new preprint explores how sex differences have shifted with more recent national prevalence surveys and growing attention to #gender responsive TB prevention and care.
bit.ly/4gqP1LH
16.09.2025 11:50 — 👍 8 🔁 6 💬 1 📌 1
Our systematic review of rural/urban differences in #TB prevalence shows evidence of rapidly urbanising epidemics in many settings, with differences across countries and regions.
Link to preprint below ⬇️
22.09.2025 07:55 — 👍 8 🔁 6 💬 0 📌 0
The potential impact, cost and cost-effectiveness of tuberculosis interventions - a modelling exercise
Background While a range of interventions exist for tuberculosis prevention, screening, diagnosis, and treatment, their potential population impact and cost-effectiveness are seldom directly compared,...
At a time when global resources for #TB research, development, prevention, and care are limited, which interventions should be prioritised in high burden settings?
📢 Our new pre-print compares the impact, cost, and cost-effectiveness of 9 TB interventions in 3 countries. 1/n
bit.ly/3V3vXth
05.09.2025 10:05 — 👍 11 🔁 9 💬 1 📌 0
Exploring trade-offs in diagnostic algorithm, population coverage, and duration of community screening for tuberculosis
Background Current tuberculosis (TB) prevention and care strategies have failed to reduce disease burden at the pace required to meet global targets. Community screening may enable more rapid declines...
Community screening for #tuberculosis could extend the reach of #TB services, but evidence on its effectiveness is limited.
In our latest preprint, we examine the epidemiological impact of trade-offs in diagnostic algorithm, population coverage, and duration of screening. 1/n
bit.ly/3UK7pFD
27.08.2025 14:55 — 👍 12 🔁 7 💬 1 📌 2
The Union's TB Undernutrition working group is hosting a webinar with Dr Matthew Saunders.
📅 21 August at 2pm CET
Dr Saunders (@lshtm.bsky.social) will share findings from a new analysis that redefines the relationship between BMI and TB incidence.
📧 To join email membership@theunion.org.
07.08.2025 13:22 — 👍 3 🔁 3 💬 0 📌 0
Reduced international donor funding through not only the termination of #USAID, but also announced reductions in donor pledges to #TheGlobalFund from other countries, could lead to substantial potential impacts on #TB morbidity and mortality.
Read how in our new study in @lancetgh.bsky.social 👇
15.07.2025 12:27 — 👍 7 🔁 4 💬 0 📌 0
Figure 1. Estimated number of trial endpoints in the control group of a prevention-of-disease vaccine trial in a high disease-burden setting showing number of endpoints on the y-axis and time in months on the x-axis. For bacteriologically confirmed symptomatic tuberculosis disease endpoints only, we estimate 69 endpoints, and for combined bacteriologically confirmed asymptomatic and symptomatic tuberculosis disease endpoints, we estimate 151 endpoints. Scenario assumes symptomatic disease incidence before trial screening of 300/100 000 per year and following 10 000 individuals over 3 years. Prevalent symptomatic and asymptomatic tuberculosis disease are screened out in month 0 and are not trial endpoints. Active screening occurs every 6 months for both scenarios and participants self-presenting with symptoms suggestive of tuberculosis disease would also be investigated.
In our latest personal view in @lancetrespirmed.bsky.social, we argue for the inclusion asymptomatic #tuberculosis in vaccine trial endpoints to potentially reduce the size, length, and cost of trials.
doi.org/10.1016/S221...
@lshtm-tbmod.bsky.social @tb-lshtm.bsky.social
04.07.2025 11:25 — 👍 14 🔁 14 💬 3 📌 0
🇨🇴🧫🧬 (they/them)
• 4th year undergrad @ mit BE
• host-pathogen interactions
• macrophage engineering & phagosomal regulation
Royal Society University Research Fellow | NUAcT Fellow @ Newcastle University @mhd-newcastle.bsky.social
Investigating mycobacterial transport systems
#structuralbiology #microbiology
Instagram @kshbeckham
Mathematical modeller in the TB modelling group at LSHTM
Public health physician and social epidemiologist passionate about addressing inequities in health and wellbeing through practice, research, and advocacy https://www.researchgate.net/profile/Matthew-Saunders-3?ev=hdr_xprf
PhD Candidate @Radboudumc | Tuberculosis | Epidemiology
Research on surveillance, prevention and control of TB & HIV & COVID and other infectious diseases. TB Research Unit Foundation of Barcelona (fuiTB).
The TB Community Coordination Hub brings together global voices of civil society, professionals, and the people and communities affected by Tuberculosis to unite to #EndTB.
https://www.tbcommunitycoordinationhub.com/
Scholar| Passionate about Mycobacterial adaptive mechanisms and how they can be targeted to improve TB treatment outcomes| Mycobacterial polyphosphate metabolism| Stress response | TB drug and drug targets Discovery
Duke University | Tobin Lab Postdoc | PharmD, PhD
Translational Scientist interested in Cell Biology — Genetics — Microbiology — Pharmacy — Innate Immunity — Zebrafish — Tuberculosis
Opinions are my own & don't represent those of my employer.
RSE at Imperial supporting macro-econ and epi modelling for pandemic response.
PhD in ecology and evol bio - I guess I only work in fields starting with E?
Mostly reposting content I agree with - email me for work stuff.
Based at LSHTM, the Global Health Economics Centre is one of the world's largest groups of global #HealthEconomics academics from a variety of research disciplines.
TB Alert is the UK’s national tuberculosis charity. We are the only charity that focuses on TB both in the UK and overseas.
Our vision is the control and ultimate elimination of TB. Our mission is to increase access to effective treatment for all.
PhD student @ i3S Porto | Tuberculosis research
Pediatrician & researcher with the vision of empowering all children to reach their full potential and live life to its fullest. @GlobalTB #EndTB #HealthForAll
My views are my own and do not reflect those of my institution.
Technical Officer at WHO’s Global Tuberculosis Programme. Committed to achieving #UHC and to #EndTB through person-centred care and the integrated management of TB and comorbidities.
One of the largest networks of TB experts in the world, harnessing diverse disciplinary expertise to end TB globally
